The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca BPC 157: Experimental Peptide Creates Risk for Athletes FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Is BPC 157 Legal? Understanding Its Status and Implications